The U.S. will pay $1.95 billion to Pfizer and BioNTech to secure hundreds of millions of doses of a Covid-19 vaccine that Americans would receive for free
As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving too quickly. WSJ’s Daniela Hernandez explains. Photo illustration: Laura KammermannPfizer Inc. and BioNTech SE said Wednesday they have signed a $1.95 billion agreement with the U.S.
Under the agreement, the U.S. government would receive 100 million doses of BNT162, the Covid-19 vaccine candidate jointly developed by Pfizer and BioNTech, and can acquire up to 500 million additional doses. Pfizer would make the vaccine.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer-BioNTech potential COVID-19 vaccine shows promise in additional dataGerman biotech firm BioNTech and U.S. drugmaker Pfizer on Monday reported additional data from their experimental COVID-19 vaccine that showed it was safe and induced an immune response in patients.
Weiterlesen »
Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, ValnevaBritain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc and BioNTech , and French group Valneva , the business ministry said on Monday.
Weiterlesen »
Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trialGerman biotech BioNTech and U.S. drugmaker Pfizer Inc on Monday said data from an early-stage trial of their experimental coronavirus vaccine showed that it prompted an immune response and was well-tolerated, similar to results seen in prior early test.
Weiterlesen »
Britain Secures 90 Million Doses Of Potential Coronavirus Vaccines From Pfizer, BioNTech & ValnevaAn effective vaccine is yet to be proven, however the U.K. has now secured access to up to 230 million vaccine doses.
Weiterlesen »
U.S. government taps Pfizer to produce millions of doses of coronavirus vaccineThe vaccine is being jointly developed by German biotech firm BioNTech and U.S.-based Pfizer.
Weiterlesen »